Association of International Pharmaceutical Manufacturers (AIPM). The Association was established in 1994. It comprises more than 50 international pharmaceutical companies that provide over 80% of the world’s pharmaceutical products and over 60% of medicines imported to the Russian Federation, which is more than 60% of the entire Russian pharmaceuticals market in money terms. AIPM mission is to promote economic and legal policies that focus on the development of organized and open pharmaceutical market, improving of medical services quality and expansion of the range of modern medicines for the benefit of Russian people.

AIPM elects Vadim Vlasov as Chairman of its Board of Directors

The Association of International Pharmaceutical Manufacturers announced that Vadim Vlasov, the President of Novartis Group Russia, was elected the Chairman of AIPM Board of Directors

Access Accelerated: Global Initiative to Advance Access to Non-communicable Disease (NCD) Prevention...

The World Economic Forum
On 18 January 2017 at the World Economic Forum in Davos, Switzerland, the international pharmaceutical industry launched the first-of-its-kind Global Initiative to advance access to non-communicable d...